Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9114042rdf:typepubmed:Citationlld:pubmed
pubmed-article:9114042lifeskim:mentionsumls-concept:C0003315lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0024518lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0162768lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0162388lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:9114042lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:9114042pubmed:issue9lld:pubmed
pubmed-article:9114042pubmed:dateCreated1997-5-27lld:pubmed
pubmed-article:9114042pubmed:abstractTextSpecificity in the immune system is dictated and regulated by specific recognition of peptide/major histocompatibility complex (MHC) complexes by the T cell receptor. Such peptide/MHC complexes are a desirable target for novel approaches in immunotherapy because of their highly restricted fine specificity. Recently, phage display was used to isolate an antibody that has T cell receptor-like specificity. It recognizes mouse MHC class I H-2Kk molecules complexed with a H-2Kk-restricted influenza virus-derived hemagglutinin peptide (Ha255-262) but does not bind to class I H-2Kk alone, peptide alone, or H-2Kk complexed with other peptides. We have used this antibody to make a recombinant antibody-toxin fusion protein (immunotoxin) and show herein that it specifically kills antigen-presenting cells in a peptide-dependent manner and with T cell receptor-like specificity. We find a striking correlation between the fine specificity of binding of the antibody and the cytotoxic activity of the recombinant immunotoxin. We also show specific killing of influenza virus-infected target cells. The results suggest that it should be possible to develop novel immunotherapeutic strategies against human cancer by making recombinant antibodies that will recognize cancer-related peptides complexed with MHC class I molecules on the surface of cancer cells and using these to deliver toxins, radioisotopes, or cytotoxic drugs to the cancer cells.lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:languageenglld:pubmed
pubmed-article:9114042pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:citationSubsetIMlld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9114042pubmed:statusMEDLINElld:pubmed
pubmed-article:9114042pubmed:monthAprlld:pubmed
pubmed-article:9114042pubmed:issn0027-8424lld:pubmed
pubmed-article:9114042pubmed:authorpubmed-author:PastanIIlld:pubmed
pubmed-article:9114042pubmed:authorpubmed-author:Di CarloAAlld:pubmed
pubmed-article:9114042pubmed:authorpubmed-author:EngbergJJlld:pubmed
pubmed-article:9114042pubmed:authorpubmed-author:FuggerLLlld:pubmed
pubmed-article:9114042pubmed:authorpubmed-author:ReiterYYlld:pubmed
pubmed-article:9114042pubmed:issnTypePrintlld:pubmed
pubmed-article:9114042pubmed:day29lld:pubmed
pubmed-article:9114042pubmed:volume94lld:pubmed
pubmed-article:9114042pubmed:ownerNLMlld:pubmed
pubmed-article:9114042pubmed:authorsCompleteYlld:pubmed
pubmed-article:9114042pubmed:pagination4631-6lld:pubmed
pubmed-article:9114042pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:meshHeadingpubmed-meshheading:9114042-...lld:pubmed
pubmed-article:9114042pubmed:year1997lld:pubmed
pubmed-article:9114042pubmed:articleTitlePeptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.lld:pubmed
pubmed-article:9114042pubmed:affiliationLaboratory of Molecular Biology, Division of Basic Sciences, National Cancer Institute, Building 37, Room 4E16, National Institutes of Health, Bethesda, MD 20892-4255, USA.lld:pubmed
pubmed-article:9114042pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9114042pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9114042lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9114042lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9114042lld:pubmed
More...